Oxford University spinout secures £14m funding to advance AI technology
- Brainomix, a University of Oxford spinout, secured £14 million in Series C funding to expand its AI stroke imaging solution in the US and support lung fibrosis treatments.
- The investment round was co-led by Parkwalk Advisors, the Boehringer Ingelheim Venture Fund, and new investor Hostplus.
- Brainomix demonstrated an additional 50% increase in patients receiving life-changing mechanical thrombectomy for strokes, showing the impact of their AI platform, Brainomix 360 Stroke.
- The funding will help Brainomix grow its Oxford operations and expand its global commercial team.
Insights by Ground AI
Does this summary seem wrong?
11 Articles
11 Articles
All
Left
Center
2
Right
Brainomix Completes £14M ($18M) Series C Round to Advance Its Transformative AI Imaging Technology in Healthcare
/PRNewswire/ -- Brainomix, a company pioneering AI-powered imaging tools in stroke and lung fibrosis, today announced the completion of a £14M ($18M) Series C...
·United States
Read Full ArticleCoverage Details
Total News Sources11
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage